Erschienen in:
01.10.2008 | Gastrointestinal Oncology
Integrated Therapy in Localized Gastric Cancer: Targeted and Tailored Approach
verfasst von:
Eva Lieto, MD, Francesca Ferraraccio, MD, PhD, Michele Orditura, MD, PhD, Paolo Castellano, MD, Anna La Mura, MD, Margherita Pinto, MD, Anna Zamboli, MD, Ferdinando De Vita, MD, PhD, Gennaro Galizia, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 10/2008
Einloggen, um Zugang zu erhalten
Excerpt
In our article, recently published in the
Annals of Surgical Oncology, vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) expression was shown to correlate with worse survival and to more accurately estimate the risk of cancer-related death than tumor–node–metastatis (TNM) stage in curatively treated gastric cancer patients. We concluded that simultaneous evaluation of VEGF and EGFR expression may be crucial to select gastric cancer patients with poor prognosis who may benefit from tailored treatments.
1 …